Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,840.00
-28.50 (-1.53%)
Sep 4, 2026, 3:14 PM IST
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 994.17 billion as of September 4, 2026. Its market cap has increased by 110.55% in one year.
Market Cap
994.17B
Enterprise Value
1.02T
Revenue
72.70B
Ranking
n/a
PE Ratio
90.96
Stock Price
1,840.00
ChartMarket Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 994.17B, an increase of 1,995.73%. That is a compound annual growth rate of 36.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 994.17B | 66.21% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.45T |
| Zydus Lifesciences | 1.14T |
| Cipla | 1.13T |
| Mankind Pharma | 987.68B |
| Aurobindo Pharma | 948.34B |
| Glenmark Pharmaceuticals | 693.93B |
| Alkem Laboratories | 622.93B |
| Ipca Laboratories | 496.37B |